Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients
Michiel E. de Jong(Radboud University Nijmegen), Frank Hoentjen(Radboud University Nijmegen), B van Ruijven(Radboud University Nijmegen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Nathan den Broeder(Radboud University Nijmegen), Lisa Smits(Radboud University Nijmegen), Rachel West(Codarts Rotterdam), Jeroen M. Jansen(OLVG), M.G.V.M. Russel(Medisch Spectrum Twente)
Cited by 75
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252
Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
|Gastroenterology|2020|233
Reduction of Colitis by Prebiotics in HLA-B27 Transgenic Rats Is Associated with Microflora Changes and Immunomodulation
|Inflammatory Bowel Diseases|2005|215
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
|Journal of Crohn s and Colitis|2019|183